-
1
Mechanistic insights into the HPF1/PARP1 complex
Published 2021“…Crucially, colleagues and I describe the interaction sites on both proteins and show that HPF1 in cells is required for the catalytic completion of PARP1 through a glutamate "finger". Furthermore, we identify the main sites of PARP1 serine auto-modification and illustrate their significance for PARP inhibitor-resistant PARP1 auto-modification and the release of PARP1 from sites of DNA damage. …”
Thesis -
2
PARP1 resolves DNA replication defects in PCNA-associated DNA repair disorder
Published 2019“…The resultant persistent single-strand breaks are processed via a back-up, PARP-dependent mechanism to ensure completion of lagging strand synthesis. …”
Thesis -
3
Role of Interferon-stimulated gene 15 (ISG15) in replication fork progression and PARP inhibitor resistance in cancer
Published 2024“…Understanding PARP (Poly-ADP ribose polymerase) inhibitor resistance is crucial in cancer therapy, particularly in treating cancers associated with BRCA mutations. …”
Thesis -
4
Identifying mechanisms involved in the resistance of homologous recombination defective Dictyostelium cells to ART inhibitors
Published 2017“…<p>Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) are toxic to cells with defects in homologous recombination (HR), which is exploited in the clinic as therapy of <em>BRCA1/2</em>-mutated tumours. …”
Thesis -
5
Caspases-3 and -7 are activated in goniothalamin-induced apoptosis in human Jurkat T-cells
Published 1999“…Activation of these caspases was further evidenced by detection of poly(ADP-ribose) polymerase cleavage (PARP). Pre-treatment with the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone (Z-VAD.FMK) blocked apoptosis and the resultant cleavage of these caspases and PARP. …”
Get full text
Article -
6
Zanthoxylum bungeanum essential oil induces apoptosis of HaCaT human keratinocytes
Published 2016“…Western blot analysis was employed to estimate the expression level of proteins including caspase-8/9/3, PARP, Bax and Bcl-2. Results: Thirty-nine compounds of the ZBEO were identified GC-MS. …”
Journal article -
7
Functional analysis of germline RAD51C missense variants highlight the role of RAD51C in replication fork protection
Published 2023“…In RAD51C deficient chinese hamster CL-V4B cells, expression of RAD51C F164S, A87E, L134S and E49K variants heightened sensitivity to mitomycin C (MMC), etoposide and PARP inhibition. Differently, expression of a subset RAD51C variants R24L, R24W, and R212H displayed mild sensitivity to MMC, etoposide and PARP inhibition. …”
Get full text
Journal Article -
8
Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells
Published 2012“…In contrast, human skin fibroblast CCL-116 and bovine primary fibroblast cells show resistances to KR and no significant changes in Bad, Bcl-XL, and cleaved PARP were observed. Our data suggest that KR selectively induces apoptosis in cancer cells through the classical mitochondria dependent apoptosis pathway.…”
Get full text
Get full text
Journal Article -
9
Ruthenium(ii) Polypyridyl complexes as FRET donors: structure- and sequence-selective DNA binding and anti-cancer properties
Published 2023“…Molecules characterized by this method demonstrate encouraging anticancer properties, including synergy with the PARP inhibitor Olaparib, and mechanistic studies indicate that [Ru(PIP)2(5,5′dmb)]2+ acts to block DNA replication fork progression.…”
Article -
10
Identification of novel functional compounds from forest onion and its biological activities against breast cancer
Published 2024“…The most promising compound was avenasterol binding PARP-1, HER2, iNOS receptors with values of −11.26, −8.34, and −9.17 μg/mL, respectively. …”
Get full text
Article -
11
Mendelian randomization identifies proteins involved in neurodegenerative diseases
Published 2025“…The newly-associated proteins indicated the involvement of complement (C1S, C1R), microglia (SIRPA, SIGLEC9, PRSS8) and lysosomes (CLN5) in AD, interleukin-6 pathway (CTF1) in PD, lysosomes (TPP1), blood–brain barrier integrity (MFAP2) and astrocytes (TNFSF13) in ALS, and blood–brain barrier integrity (VEGFB), oligodendrocytes (PARP1), node of Ranvier and dorsal root ganglion (NCS1, FLRT3, CDH15), and innate immune system (CR1, AHSG, WARS) in MS. …”
Journal article -
12